Amvia-Solvia Pulse Generators Scan Duration Extension
Biotronik, Inc. · Decision date Mar 30, 2026
What did the FDA approve?
FDA records P950037/S282 as a supplement to PMA P950037, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Mar 30, 2026.
FDA approval order statement
Approval for extending the MRI scan duration to at least 60 minutes and additional MRI follow up and labeling updates.
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Cardiovascular
- Decision date
- Mar 30, 2026
- FDA change category
- Labeling Change - Indications/instructions/shelf life/tradename
Regulatory record facts
- Identifier
- P950037/S282
- Regulatory pathway
- PMA supplement
- Applicant
- Biotronik, Inc.
- Product code
- DXY
- Decision code
- APPR
- Decision date
- Mar 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: implantable pacemaker Pulse-generator.
- Applicant
- Biotronik, Inc.
- Product code
- DXY
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P950037. Subsequent supplements may change the device or its indications.
FDA decision timeline
P950037 · Original PMA
DROMOS DR/DR-A AND DROMOS SR/SR-B CARDIAC PACING SYSTEMS
P950037/S275 · Related supplement
Edora 8 DR-T (407145); Evity 8 DR-T (407146); Enitra 8 DR-T (407147); Enticos 8 DR-T (407148); Evity 6 DR-T (407149); En
P950037/S276 · Related supplement
Edora 8 DR-T (407145); Evity 8 DR-T (407146); Enitra 8 DR-T (407147); Enticos 8 DR-T (407148); Evity 6 DR-T (407149); En
P950037/S277 · Related supplement
Edora 8 DR-T; Evity 8 DR-T; Enitra 8 DR-T; Enticos 8 DR-T; Evity 6 DR-T; Enitra 6 DR-T; Edora 8 DR; Enitra 6 DR; Edora 8
P950037/S278 · Related supplement
Edora 8 DR-T 407145, Evity 8 DR-T 407146, Enitra 8 DR-T 407147, Enticos 8 DR-T 407148, Evity 6 DR-T 407149, Enitra 6 DR-
P950037/S272 · Related supplement
Edora 8 DR-T; Evity 8 DR-T; Enitra 8 DR-T; Enticos 8 DR-T; Evity 6 DR-T; Enitra 6 DR-T; Edora 8 DR; Enitra 6 DR; Edora 8
P950037/S281 · Related supplement
Siello T 53; Siello T 60; Siello JT 45; Siello JT 53; Solia T 53; Solia T 60; Solia JT 45; Solia JT 53; Siello S 45; Sie
P950037/S274 · Related supplement
Solia S 53 377177; Solia S 60 377179
P950037/S282 received
Application receipt date recorded by FDA.
P950037/S284 · Related supplement
DROMOS DR/DR-A AND DROMOS SR/SR-B CARDIAC PACING SYSTEMS
P950037/S283 · Related supplement
DROMOS DR/DR-A AND DROMOS SR/SR-B CARDIAC PACING SYSTEMS
P950037/S280 · Related supplement
Solia CSP S 53; Solia CSP S 60
P950037/S286 · Related supplement
Edora 8 DR-T (407145); Evity 8 DR-T (407146); Enitra 8 DR-T (407147); Enticos 8 DR-T (407148); Evity 6 DR-T (407149); En
P950037/S287 · Related supplement
Pulse Generator, Permanent Implantable Edora 8 DR-T Evity 8 DR-T Enitra 8 DR-T Enticos 8 DR-T Evity 6 DR-T Enitra 6 DR-T
P950037/S282 · FDA decision
Real-Time Process
P950037/S288 · Related supplement
Solia CSP S Leads
P950037/S285 · Related supplement
Renamic Neo
P950037/S290 · Related supplement
Edora 8 DR-T, Evity 8 DR-T, Enitra 8 DR-T, Evity 6 DR-T, Enitra 6 DR-T, Edora 8 DR, Enitra 6 DR, Edora 8 SR-T, Evity 8 S
P950037/S292 · Related supplement
Drug Eluting Permanent Right Ventricular (RV) or Right Atrial (RA) Pacemaker Electrodes
P950037/S293 · Related supplement
Siello T 53, Siello T 60, Siello JT 45, Siello JT 53, Solia T 53, Solia T 60, Solia JT 45, Solia JT 53, Siello S 45, Sie
P950037/S295 · Related supplement
Solia T 53, Solia T 60, Solia S 45, Solia S 53, Solia S 60, Solia CSP S 53, Solia CSP S 60
P950037/S297 · Related supplement
Solia CSP S
P950037/S291 · Related supplement
PSW 2601.U, NEO 2601.U, Amvia Sky HF-T QP, Amvia Sky HF-T, Amvia Edge HF-T QP, Amvia Sky DR-T, Amvia Sky SR-T, Amvia Edg
P950037/S279 · Related supplement
Edora 8 DR-T 407145, Evity 8 DR-T 407146, Enitra 8 DR-T 407147, Enticos 8 DR-T 407148, Evity 6 DR-T 407149, Enitra 6 DR-
P950037/S296 · Related supplement
Edora 8 DR-T 407145; Evity 8 DR-T 407146; Enitra 8 DR-T 407147; Enticos 8 DR-T 407148; Evity 6 DR-T 407149; Enitra 6 DR-
P950037/S298 · Related supplement
Edora 8 DR-T, Evity 8 DR-T, Enitra 8 DR-T, Evity 6 DR-T, Enitra 6 DR-T, Edora 8 DR, Enitra 6 DR, Enticos 4 DR, Enticos
P950037/S289 · Related supplement
BIOexpress
P950037/S299 · Related supplement
Edora 8 DR-T, Evity 8 DR-T, Enitra 8 DR-T, Enticos 8 DR-T, Evity 6 DR-T, Enitra 6 DR-T, Edora 8 DR, Enitra 6 DR, Edora 8
P950037/S300 · Related supplement
Amvia Sky DR-T, Amvia Sky SR-T; Amvia Edge DR-T, Amvia Edge SR-T; Solvia Rise DR-T, Solvia Rise SR-T; Amvia Sky HF-T QP,
Timeline entries are records held by MedtechLedger for P950037. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P950037
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Biotronik, Inc. | PMA approval | Oct 11, 1996 | FDA | |
| Biotronik, Inc. | PMA supplement | Sep 11, 2025 | FDA | |
| Biotronik, Inc. | PMA supplement | Sep 15, 2025 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 1, 2025 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 16, 2025 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 24, 2025 | FDA | |
| Biotronik, Inc. | PMA supplement | Dec 10, 2025 | FDA | |
Solia S 53 377177; Solia S 60 377179P950037/S274 | Biotronik, Inc. | PMA supplement | Dec 18, 2025 | FDA |
| Biotronik, Inc. | PMA supplement | Feb 3, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Feb 11, 2026 | FDA | |
Solia CSP S 53; Solia CSP S 60P950037/S280 | Biotronik, Inc. | PMA supplement | Feb 12, 2026 | FDA |
| Biotronik, Inc. | PMA supplement | Mar 5, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Mar 27, 2026 | FDA | |
Solia CSP S LeadsP950037/S288 | Biotronik, Inc. | PMA supplement | Apr 2, 2026 | FDA |
Renamic NeoP950037/S285 | Biotronik, Inc. | PMA supplement | Apr 24, 2026 | FDA |
| Biotronik, Inc. | PMA supplement | May 7, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | May 15, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | May 28, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Jul 1, 2026 | FDA | |
Solia CSP SP950037/S297 | Biotronik, Inc. | PMA supplement | Aug 27, 2026 | FDA |
| Biotronik, Inc. | PMA supplement | Sep 17, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Sep 25, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 9, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 13, 2026 | FDA | |
BIOexpressP950037/S289 | Biotronik, Inc. | PMA supplement | Oct 16, 2026 | FDA |
| Biotronik, Inc. | PMA supplement | Oct 22, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 28, 2026 | FDA |
Explore the linked device profile
Other records with product code DXY
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Jul 21, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Biotronik, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 6024 Jean Rd., Lake Oswego, OR, 97035
Sources and methodology
- Original FDA record: P950037/S282
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records







